Cytek Biosciences, Inc. (CTKB) Beats Q2 Earnings Estimates

Cytek Biosciences, Inc. (CTKB) came out with quarterly earnings of $0.01 per share, beating the Zacks Consensus Estimate of a loss of $0.02 per share. This compares to a loss of $0.08 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +150.00%. A quarter ago, it was expected that this company would post a loss of $0.04 per share when it actually produced a loss of $0.09, delivering a surprise of -125%.Over the last four quarters, ...